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A B S T R A C T
Calcineurin (CaN) is a neuronally enriched, calcium-dependent phosphatase, which plays an important
role in a number of neuronal processes including development of learning andmemory, andmodulation
of receptor’s function and neuronal excitability as well as induction of apoptosis. It has been established
in kindling model that the status epilepticus (SE)-induced increase in CaN activity is involved in the
development of seizures through down-regulation of g-aminobutyric acid A receptor (GABAAR)
activation. However, the mechanism by which CaNmediates GABAA receptor dephosphorylation in SE is
not fully understood. Here, using a model of kainic acid (KA)-induced SE and CaN inhibitor FK506, we
observed the behaviors induced by KA and levels of CaN activity and CaN expression in hippocampus by
immunobloting. The results showed that the SE-induced CaN activity was time-dependent, with a peak
at 2 h and a return to basal level at 24 h, whereas a signiﬁcant increase in CaN expression was seen at
24 h after SE. It is proposed that the rapid elevation in CaN activity after KA-induced SE is not likely due to
an increase in CaN expression but rather an increase in CaN activation state or kinetics. In addition, we
also demonstrated that pre-treatment with FK506 remarkably suppressed the SE-induced CaN activity
and its expression, and reversed the SE-induced dephosphorylation of GABAAR 2/3 subunits. Taken
together, our data suggest that down-regulation in inhibition of GABAAR 2/3 by CaN activity contributes
to an elevation in neuronal excitability of hippocampus, which may be involved in development of
chronic processes of seizures.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Status epilepticus (SE) may cause long-term functional and
structural consequences possibly resulting in brain dysfunctions
such as chronic epilepsy.1 There is physiological and neurochemical
changeswhich take place during the seizure activity.2 These cellular
and molecular alterations may later manifest themselves as
spontaneous recurrent seizure activity, through a process known
as epileptogenesis.2 Notably, calcium and calcium-regulated sys-
tems have been found to be closely associated with generation of
seizures.3 Of these, one calcium-regulated enzyme of particular
interest is the calcium-stimulated phosphatase, calcineurin (CaN).
CaN is a member of the serine/threonine protein phosphatase
family enriched in neural tissue.4 It has been found that CaN-Abbreviations: SE, status epilepticus; KA, kainic acid; CaN, calcineurin; GABAAR, g-
aminobutyric acid receptor; SD, standard deviation.
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doi:10.1016/j.seizure.2009.05.001mediated dephosphorylation is an important process in the
control of many cellular processes including development of
learning and memory,5 regulation of long-term potentiation,6
modulation of neurotransmitter release,7 as well as induction of
apoptosis.8 Additionally, CaN is reported to take its action in
inhibiting the activity of the GABA receptor,9 regulating gene
transcription and affecting cytoskeletal architecture.10,11 Recent
studies have demonstrated that SE may lead to a rapid increase in
CaN activity in hippocampus and cortex that may be necessary
for the development of seizures in a kindling model.12 However,
the SE-induced increase in CaN activity is not consistent with
that in CaN expression, suggesting that the delayed expression of
CaN may contribute to a long-lasting neuronal excitability of the
hippocampus.12 A further study revealed that phosphorylation of
GABAAR b2/3 subunits was down-regulated by hypoxia-induced
seizures, whereas this effect was reversed by CaN inhibitor
FK506. These ﬁndings suggest that CaN may mediate depho-
sphorylation of GABAAR b2/3 subunits, by which inhibition of
GABAAR contributes to subsequent neuronal hyperexcitability
after seizures.13 Despite many cellular and molecular mechan-
isms linked to epileptogenesis have been intensively investi-vier Ltd. All rights reserved.
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elucidated.
In the present study, we characterize the alterations of CaN
activity, protein expression and phosphorylation of GABAAR in
hippocampus after KA-induced SE. Western blot analysis demon-
strated that a time-dependent increase in CaN activity and protein
expression, and a down-regulation of GABAAR phosphorylation
induced by SE. These changes were shown to have different
responses to FK506, with attenuation of CaN activity and its
protein expression and inhibition of GABAAR dephosphorylation.
This raises the possibilities that CaN plays an important role in
epileptogenesis via dephosphorylation of GABAAR, and that CaN
inhibitor such as FK506 may have clinical potential in the
treatment of refractory seizures.
2. Experimental procedures
2.1. Experimental animals
Adult male Wistar rats (Experimental Animal Center of
Shandong University, China) weighing 180–270 g were used.
Animals were maintained in a temperature-controlled room
(26 8C) with a 12 h light/dark cycle and free access to food and
water. The experimental procedures were approved by the
Commission of Shandong University for the ethics of experiments
on animals, in accordance with international standards. Seizures
were scored using a modiﬁed Racine scale.14
2.2. Pre-treatment of animals
The animals were divided into ﬁve groups (25 rats in each
group, n = 125): a control group (no pre-treatment, followed by
saline, 0.9%); a KA group (no pre-treatment, followed by KA); a
KA + saline group (saline pre-treatment, followed by KA after
0.5 h); an FK506 group (FK506 pre-treatment, followed by KA after
0.5 h); and a rapamycin group (rapamycin pre-treatment, followed
by KA after 0.5 h). The CaN inhibitor, FK506 (Fujisawa, Japan) was
administered as a single i.p. bolus at 2 mg/kg bw; and the
immunosuppressant (but not CaN inhibitor) rapamycin (Sigma)
was administered as a single i.p. bolus at 10 mg/kg bw.
2.3. Induction of status epilepticus
Seizures were induced by intracerebroventricular injection of
KA (Sigma, USA). Brieﬂy, rats were anaesthetized with intraper-
itoneal (i.p.) pentobarbital (50 mg/kg, Sigma) and were placed in a
stereotaxic frame. Then 0.5 mg of KA dissolved in 1.0 ml of 0.9%
NaCl was injected by microsyringe following the stereotaxic
coordinates: 0.85 mm caudal, 1.5 mm lateral, and 4.3 mm deep,
relative to the bregma. Only rats with sustained generalizedmotor
seizures that scored 4–5 on the Racine scale were included in the
experimental groups. Seizureswere allowed to continue for 30 min
and were terminated by an injection of diazepam (i.p., 10 mg/kg,
Sigma). The proportions of animals having stage 4 and 5 seizures
were 92%, 88%, 84%, and 88% in the KA, KA + saline, FK506, and
rapamycin groups, respectively (p > 0.05).
2.4. Sample preparation
Four animals from each group were decapitated at 2, 6, 12, 24
and 72 h after SE induction to analyze for CaN activity, CaN protein
expression and GABAAR dephosphorylation. Brains were dissected
in Petri dishes on ice in order to preserve postmortem enzyme
activity. Hippocampus was isolated and immediately homoge-
nized in ice-cold homogenization buffer containing 5 mM HEPES
(pH 7.0), 7 mM EGTA, 5 mM EDTA, 1 mM dithiothreitol (DTT),0.3 mM phenylmethyl sulfonyl ﬂuoride (PMSF), and 300 mM
sucrose. The samples were then centrifuged at 12,000 rpm for
10 min at 4 8C, and stored at 80 8C.
2.5. CaN activity assay
CaN activity was assayed using the procedure detailed by Kurz
et al.12 All reaction tubes were prepared on ice and contained the
following: 25 mMmorpholinopropanesulfonic acid, pH 7.0, 1 mM
DTT, 2 mM p-nitrophenol phosphate (pNPP), and 150 nM okadaic
acid. Basal tubes also contained 2 mM EGTA and 2 mM EDTA,
while the treated tubes contained 2 mM MnCl2. Mn
2+ activates
CaNmore strongly thanCa2+,15 andMn2+was therefore used in the
maximal reactions in order to maximize the cation-stimulated
activity of the enzyme. Reactions were incubated at 37 8C for
30 min in a shakingwater bath. Prior to use, protein concentration
of all homogenates was determined using the method of
Bradford.16 Tubes were then removed from the water bath and
placed on ice to stop the reaction. The absorbance of the reaction
mixture was immediately measured at 405 nm in a plate reader,
and absorbance units were converted to mg/ml of PNP (p-
nitrophenol) produced by comparison with a pNP concentration
standard absorption curve.
2.6. Immunoblotting
Forty micrograms of protein was separated by sodium dodecyl
sulfate-polyacrylamide (SDS) gel electrophoresis and then trans-
ferred into nitrocellulose membranes. After blocking in 5% fat-free
milk for 1 h, the membranes were incubated with primary
antibodies to CaN (1:13,000, Sigma), and GABAAR 2/3 (1:500,
Boehringer Mannheim, Germany) at 4 8C overnight. They were
then incubated with horseradish peroxidase-conjugated second
antibodies (1:3000, Santa Cruz Biotechnology, CA, USA) for 1 h.
Immunoreactivity was enhanced using a chemiluminescence kit
(Pierce, Rockford, IL, USA) and preparations were exposed to ﬁlm.
The bands were scanned and analyzed using an image analyzer
(Alpha Innotech, San Leandro, CA, USA).
2.7. Data analysis
The data are shown as the means  SEM. Statistical analysis was
performed using one-way ANOVA followed by Newman–Keuls test
with SPSS 12.0 (SPSS Inc., USA). The proportion of animals with stage
4 and 5 seizures was analyzed by x2 test. Statistical signiﬁcance was
accepted at the conventional p < 0.05 level.
3. Results
3.1. Behavioral episodes
Behavioral episodes induced by KA followed the typical course
of seizures, with a gradual increase in intensity to SE. No
differences in behavioral seizures were noted in these rats pre-
treated with or without FK506. Control animals did not exhibit any
behavioral seizure activity.
3.2. Characteristics of CaN activity in rats with KA-induced SE
To determine if CaN levels were elevated after KA-induced SE,
we measured CaN activity at 2, 6, 12, 24 and 72 h after SE. The
results showed that a signiﬁcant increase in both basal and
maximal CaN activity was seen after SE, with a peak at 2 h
(p < 0.01), and a return to basal levels after 24 h (Fig. 1A). We also
observed that pre-treatmentwith FK506 remarkably decreased the
SE-induced CaN activity at 2 h (p < 0.01) (Fig. 1A0). It is therefore
Fig. 1. Changes in CaN phosphatase activity after KA-induced SE. (A) Basal and
maximal CaN activity levels after SE. (A0) The effect of FK506 on CaN activity. When
FK506 was administered prior to KA injection, CaN activity was signiﬁcantly
decreased at 2 h after SE. Bars indicate averages  SD. *p < 0.05, **p < 0.01 vs. control
(basal). #p < 0.05, ##p < 0.01 vs. control (max.). &&p < 0.01 vs. KA and KA + saline
(basal). ++p < 0.01 vs. KA and KA + saline (max.).
Fig. 3. The effect of FK506 on CaN protein expression at 72 h after SE. (A)
Immunoblot showing the effect of FK506 on CaN protein expression. (A0) Western
blot datawere densitometrically quantiﬁed and normalized to an internal standard.
Bars indicate averages  SD. **p < 0.01 vs. control; #p < 0.05 vs. KA and KA + saline.
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and also is inhibited by FK506.
3.3. Characteristics of CaN protein expression in KA-induced SE
In order to determine whether the observed increase in CaN
activity induced by SE was associated with the CaN protein
expression, the total CaN protein levels in hippocampus at 2, 6, 12,
24 and 72 h after SEweremeasured by usingWestern blot analysis.
As shown in Fig. 2A and A0, immunoblots indicated that a
signiﬁcant increase in CaN protein expressionwas observed at 24 h
after SE (p < 0.05), and still remained until 72 h (p < 0.01). Taking
together with the SE-induced CaN activity in time course, it is
suggested that the SE-induced increase in CaN activity does not
depend on CaN protein expression. In addition, pre-treatment with
FK506 has been shown to result in inhibition of CaN protein
expression at 72 h after SE (p < 0.05) (Fig. 3A and A0), demonstrat-Fig. 2. Immunoblot analysis of CaN protein expression. (A) Immunoblot showing
CaN protein expression (64 kD). (A0) Western blot data were densitometrically
quantiﬁed and normalized to an internal standard. Bars indicate averages  SD.
*p < 0.05, **p < 0.01 vs. control.ing that FK506 can inhibit not only CaN activity but also CaN
protein expression induced by SE.
3.4. Dephosphorylation of GABAAR 2/3 subunits induced by SE
Wemeasured phosphorylation state of GABAAR 2/3 subunits at
2, 6, 12, 24 and 72 h after SE induction using anti-phosphoserine/
threonine antibodies against immunoprecipitated GABAAR 2/3
subunit protein. At 2, 6, 12 and 24 h after SE, the level of
phosphorylation of serine/threonine residues in GABAAR 2/3
subunits was signiﬁcantly decreased (p < 0.01, p < 0.01,
p < 0.05, p < 0.05, respectively), with no alteration in total 2/3
subunit protein (p > 0.05) (Fig. 4A and A0).We also investigated the
association between FK506 and the phosphorylation state of
GABAAR 2/3 subunits after SE induction. FK506 signiﬁcantly
increased the level of phosphorylation of serine/threonine residues
at 2 h after SE (p < 0.05) (Fig. 5A and A0).Fig. 4. Immunoblot analysis of phosphorylation of serine/threonine residues in
GABAAR 2/3 subunits. (A) Immunoblot showing phosphorylation of serine/
threonine. (A0) Western blot data were densitometrically quantiﬁed and
normalized to an internal standard. Bars indicate averages  SD. *p < 0.05,
**p < 0.01 vs. control.
Fig. 5. The effect of FK506 on phosphorylation of serine/threonine residues in
GABAAR 2/3 subunits at 2 h after SE. (A) Immunoblot showing the effect of FK506 on
phosphorylation of serine/threonine residues in GABAAR 2/3 subunits. (A0) Western
blot datawere densitometrically quantiﬁed and normalized to an internal standard.
Bars indicate averages  SD. *p < 0.05, **p < 0.01 vs. control; #p < 0.05 vs. KA and
KA + saline; &p < 0.05 vs. KA and KA + saline.
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To determine if the effects of FK506 on GABAAR depho-
sphorylation could have been caused by actions other than CaN
inhibition, we examined the effects of immunosuppressant
rapamycin (Sigma, 10 mg/kg, i.p.). Rapamycin is a derivative of
FK506 that also binds to the immunophilin FKBP12, but, unlike
FK506, the FKBP12–rapamcyin complex does not inhibit CaN
activity.17 Compared with KA group, no signiﬁcant changes in
GABAAR dephosphorylation were observed after rapamycin
administration (Fig. 5A and A0). This suggests that the effects of
FK506 on GABAAR dephosphorylation were mediated by its ability
to inhibit CaN activity.
4. Discussion
In our study, we found that KA-induced seizures resulted in a
rapid increase in basal andmaximal CaN activity and a delayed CaN
protein expression. This lead us to speculate that a acute increase
in CaN activity after SE was not due to a rapid increase in CaN
protein expression, but rather to an increase in CaN activation state
or kinetics. These results are supported by the study in adult SE
models.18
There are several possible mechanisms that could account for
the increase in CaN activity. As a calcium/calmodulin-stimulated
enzyme, CaN can be stimulated by increased intracellular Ca2+
concentrations.19 After SE, the function of Mg2+/Ca2+ ATPase that
regulates intracellular Ca2+ concentrations is lost,20,21 and ATPase-
mediated uptake of Ca2+ into themicrosomes is also less efﬁcient,20
which could potentially result in higher than normal resting
intracellular Ca2+ concentrations.3 The increased intracellular Ca2+
associated with SE could be responsible for activating CaN above
its normal physiological level.
On the other hand, the increase in CaN activitymay be related to
the activation of inﬂammatory induced by SE. An increasing body
of evidence demonstrates that seizure activates inﬂammatory
cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), tumor
necrosis factor (TNF-a) and the related pro- and anti-inﬂammatory
genes in glia.22,23 These inﬂammatory cytokines may contribute to
altered neuronal network excitability and consequently affect the
down-stream events involved in epileptogenesis and pathologicchanges.24 Therefore, CaN activity could not only regulate
inﬂammatory cytokines but also be triggered by pro-inﬂammatory
cytokines such as IL-1b and TNF-a.25
Additionally, the increase in CaN activity may be associated
with an opening of the blood–brain-barrier (BBB). The BBB
disruption and opening are shown in epileptic rats and humans,
both shortly after SE as well as in the chronic epileptic phase.26
Changes in BBB integrity may be caused by increase local blood
pressure that occurs during seizure,27 free radical formation,28 and
inﬂammation responses.22 BBB leakage may contribute to the
increased excitability and development of calcium waves in
astrocyte,26 which activate NMDA receptors through feed-forward
synaptic activation. CaN activation is modulated via NMDA
channel-mediated calcium inﬂux.12
GABAAR is the primary receptor responsible for the fast
inhibitory response in neuronal tissue, and plays a major role in
preventing the neuronal hyperexcitability associated with epi-
lepsy and SE. The serine/threonine residues within the GABAAR 2/
3 subunits are key residues for modulating GABAAR function,
29
and dephosphorylation by CaN can decrease GABAAR-mediated
responses to GABA30 and cell surface GABAAR stability.
31 In this
study, we showed that a decrease in serine/threonine phosphor-
ylation of GABAAR at 2–12 h after SE induction was coincident
with an increase in CaN activity. These ﬁndings suggest that
GABAARs are likely targets of CaN-mediated dephosphorylation,
and that the longer term production of chronic epilepsy are
attributable, at least in part, to GABAAR dephosphorylation. A
previous study also demonstrated that CaN activation resulted in
down-regulation of synaptic GABAergic inhibition.32 Although
the dephosphorylation of serine/threonine within the GABAA 2/3
subunit may be mediated by multiple mechanisms, our results
suggest that CaN plays a role in this modulation. The increase in
CaN protein expression at 24 h post-SE may be related to the
decrease in serine/threonine phosphorylation of the GABAAR at
24 h after SE, which causes development of chronic refractory
seizures. However, upon the increase in CaN protein expression,
no change in GABAAR phosphorylation at 72 h after SE induction
may be correlated with other mechanisms, which need to be
further studied.
Similar to the reported by Sanchez et al.,13 FK506 was shown
to inhibit CaN activity, CaN protein expression and GABAAR
dephosphorylation in our study. Additionally, we also investi-
gated the effects of the immunosuppressant rapamycin in order
to establish if the effects of FK506 on GABAAR dephosphorylation
could have been caused by actions other than CaN inhibition.
Rapamycin is a derivative of FK506 that also binds to the
immunophilin FKBP12. However, unlike FK506, the FKBP12–
rapamcyin complex does not inhibit CaN activity.10 In our
current model, we found that application of rapamycin had no
signiﬁcant effect on GABAAR dephosphorylation after KA-
induced seizures. Despite FK506 could reverse CaN-mediated
dephosphorylation of GABAAR, FK506 did not prevent seizures in
our study. We speculate that loss of GABAAR integrity is involved
in kindling as a delayed mechanism able to reduce the seizure
threshold.
Overall, CaN plays a pivotal/important role in SE induction via
mediation of GABAAR dephosphorylation. FK506 has the potential
to acutely decrease hippocampal excitability and disrupt long-
term epileptogenesis. It is therefore believed that CaN inhibitor
has clinical potential for the treatment of chronic refractory
seizures.
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